PTP1B inhibition promotes microglial phagocytosis in Alzheimer’s disease models by enhancing SYK signaling
Proceedings of the National Academy of Sciences · 10.02.2026 · 123 (6)
DOI: 10.1073/pnas.2521944123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 02.02.2026. Verfasst von Yuxin Cen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724. Hauptthemen laut MEDLINE: Protein Tyrosine Phosphatase, Non-Receptor Type 1, Syk Kinase, Alzheimer Disease, Microglia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Coins for Alzheimer's Research Trust (CART), NIH HHS, Irving A. Hansen Memorial Foundation.
Themen: Demenz
Abstract (Originalsprache)
Amyloid β (Aβ) accumulation is a hallmark of Alzheimer’s disease (AD). Emerging evidence suggests that impaired microglial Aβ phagocytosis is a key feature in AD, highlighting the therapeutic potential of enhancing this innate immune function. Here, we demonstrate that genetic deletion or pharmacological inhibition of protein tyrosine phosphatase 1B (PTP1B) ameliorated memory deficits and reduced Aβ burden in APP/PS1 mice. Moreover, we show that PTP1B was highly expressed in microglia, and its deficiency promoted a transcriptional shift toward immune activation and phagocytosis. Consistently, PTP1B deletion in microglia enhanced phagocytosis and energy metabolism, supported by increased AKT-mTOR signaling, a pathway essential for meeting the energy demands of activation. Mechanistically, we identified spleen tyrosine kinase (SYK), a key regulator of microglial phagocytosis, as a direct substrate of PTP1B. Inhibition of SYK showed that PTP1B modulates microglial activation in a SYK-dependent manner. These findings established PTP1B as a critical modulator of microglial activation and a potential therapeutic target for AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724.
- Graduate Program in Molecular and Cellular Biology, Stony Brook University, Stony Brook, NY 11794.
ORCID-Profile: Steven R Alves, Dongyan Song, Linda Van Aelst
Förderung
- Coins for Alzheimer's Research Trust (CART)
- NIH HHS
- Irving A. Hansen Memorial Foundation
- NINDS NIH HHS
- NCI NIH HHS
- NIMH NIH HHS
- CSHL Cancer Center Support Grant
- Coins for Alzheimer’s Research Trust
Zitieren
APA
Cen, Y., R Alves, S., Song, D., Felice, C., Preall, J. B., Van Aelst, L., & Tonks, N. K. (2026). PTP1B inhibition promotes microglial phagocytosis in Alzheimer’s disease models by enhancing SYK signaling. Proceedings of the National Academy of Sciences, 123(6). https://doi.org/10.1073/pnas.2521944123
Vancouver
Cen Y, R Alves S, Song D, Felice C, Preall JB, Van Aelst L, et al. PTP1B inhibition promotes microglial phagocytosis in Alzheimer’s disease models by enhancing SYK signaling. Proceedings of the National Academy of Sciences. 2026;123(6). doi:10.1073/pnas.2521944123
BibTeX
@article{Cen2026,
author = {Cen, Yuxin and R Alves, Steven and Song, Dongyan and Felice, Christy and Preall, Jonathan B and Van Aelst, Linda and Tonks, Nicholas K},
title = {PTP1B inhibition promotes microglial phagocytosis in Alzheimer’s disease models by enhancing SYK signaling},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
volume = {123},
number = {6},
doi = {10.1073/pnas.2521944123}
}
EUVIMED